Please use this identifier to cite or link to this item:
|Title:||Striatal dopaminergic neurons are lost with Parkinson's disease progression.||Austin Authors:||Porritt, Michelle J;Kingsbury, Ann E;Hughes, Andrew J ;Howells, David William||Affiliation:||Austin Health, Department of Medicine, University of Melbourne, Victoria, Australia||Issue Date:||1-Dec-2006||Publication information:||Movement Disorders : Official Journal of the Movement Disorder Society; 21(12): 2208-11||Abstract:||Increased numbers of dopaminergic neurons are described in the striatum of patients with Parkinson's disease. In postmortem striatal tissue from Parkinson's disease patients with short disease duration (< or =8 years), the number of dopaminergic neurons is approximately four times that in patients with long duration (> or =16 years). The data suggest the possibility that the presence of large numbers of these striatal dopaminergic neurons may be harmful and may accelerate the disease process. Alternatively, these neurons may be lost to the disease process.||Gov't Doc #:||17029264||URI:||https://ahro.austin.org.au/austinjspui/handle/1/10247||DOI:||10.1002/mds.21129||Journal:||Movement disorders : official journal of the Movement Disorder Society||URL:||https://pubmed.ncbi.nlm.nih.gov/17029264||Type:||Journal Article||Subjects:||Aged
Aged, 80 and over
|Appears in Collections:||Journal articles|
Show full item record
checked on Dec 7, 2023
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.